Glucagon‐like peptide 1 (
                    GLP1
                    ) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials

Giovanni Antonio Silverii; Laura Pala; Barbara Cresci; Edoardo Mannucci

doi:10.1111/dom.16076

journal article Open Access Nov 20, 2024

Glucagon‐like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials

Giovanni Antonio Silverii

Laura Pala Barbara Cresci

Edoardo Mannucci

Diabetes, Obesity and Metabolism Vol. 27 No. 2 pp. 1005-1009 · Wiley

View at Publisher Save 10.1111/dom.16076

Topics

No keywords indexed for this article. Browse by subject →

References

16

[1]

10.1038/s41591‐023‐02538‐7

[2]

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff, Kirstine Brown-Frandsen, Helen M. Colhoun et al.

New England Journal of Medicine 10.1056/nejmoa2307563

[3]

10.1056/nejmoa2306963

[4]

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

Mikhail N. Kosiborod, Mark C. Petrie, Barry A. Borlaug et al.

New England Journal of Medicine 10.1056/nejmoa2313917

[5]

10.1056/nejmoa2403347

[6]

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Steven P. Marso, Stephen C. Bain, Agostino Consoli et al.

New England Journal of Medicine 10.1056/nejmoa1607141

[7]

10.1007/s00417‐023‐06236‐5

[8]

10.1001/jamaophthalmol.2024.2296

[9]

10.1016/s0002‐9394(14)70999‐7

[10]

10.1097/wno.0000000000002102

[11]

10.1007/s00417‐023‐06103‐3

[12]

10.1111/dom.13339

[13]

10.1186/s13643‐021‐01626‐4

[14]

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A C Sterne, Jelena Savović, Matthew J Page et al.

BMJ 10.1136/bmj.l4898

[15]

10.1111/dom.15226

[16]

10.1001/jamaophthalmol.2023.2289

Metrics

28

Citations

16

References

Details

Published: Nov 20, 2024
Vol/Issue: 27(2)
Pages: 1005-1009
License: View

Authors

G

Giovanni Antonio Silverii

Experimental and Clinical Biomedical Sciences ‘Mario Serio’ Department University of Florence Florence Italy

L

Laura Pala

Diabetology Unit AOU Careggi Florence Italy

B

Barbara Cresci

Diabetology Unit AOU Careggi Florence Italy

E

Edoardo Mannucci

Experimental and Clinical Biomedical Sciences ‘Mario Serio’ Department University of Florence Florence Italy

Cite This Article

Giovanni Antonio Silverii, Laura Pala, Barbara Cresci, et al. (2024). Glucagon‐like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials. Diabetes, Obesity and Metabolism, 27(2), 1005-1009. https://doi.org/10.1111/dom.16076

Glucagon‐like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials

You May Also Like